<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04317235</url>
  </required_header>
  <id_info>
    <org_study_id>SaintgeorgeH</org_study_id>
    <nct_id>NCT04317235</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis</brief_title>
  <official_title>Ropivacaine for Ultrasound-guided Interscalene Block: 3mL Provide Similar Analgesia to 5mL With Less Diaphragmatic Paralysis in Shoulder Arthroscopy Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint George Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint George Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL
      with less diaphragmatic paralysis in shoulder arthroscopy surgeries
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL
      with less diaphragmatic paralysis in shoulder arthroscopy surgeries with no toxicity and no
      adverse reaction or complications we targeted under echography each nerve to be blocked alone
      either to put around all the nerves a big volume
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2016</start_date>
  <completion_date type="Actual">January 20, 2019</completion_date>
  <primary_completion_date type="Actual">March 2, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic paralysis</measure>
    <time_frame>Up to 48 hours</time_frame>
    <description>on x ray we look if there is an elevated diaphragm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain relief</measure>
    <time_frame>up to day 2 after operation</time_frame>
    <description>pain scale 1-10 score 1 no pain and 10 severe pain first by visiting patient before discharge twice and thereafter on the phone</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Diaphragmatic Paralysis</condition>
  <arm_group>
    <arm_group_label>3 ml ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>interscalene block using 3 ml under ultrasound put medication on each nerve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 ml ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>interscalene block using 5 ml under ultrasound put medication on each nerve</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% Injectable Solution</intervention_name>
    <description>Is to put 3 ml or 5 ml and show the difference</description>
    <arm_group_label>3 ml ropivacaine</arm_group_label>
    <arm_group_label>5 ml ropivacaine</arm_group_label>
    <other_name>interscalene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA1-2

        Exclusion Criteria:

          -  ASA3-4 anticoagulant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hazem kafrouni</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint George Hospital</affiliation>
  </overall_official>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 23, 2019</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2020</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint George Hospital</investigator_affiliation>
    <investigator_full_name>Hazem Kafrouni</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Paralysis</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

